Acropolis Investment Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Buy |
4,657
+78
| +2% | +$29.9K | 0.1% | 72 |
|
|
2025
Q1 | $1.58M | Buy |
4,579
+47
| +1% | +$16.2K | 0.09% | 80 |
|
|
2024
Q4 | $1.36M | Buy |
4,532
+12
| +0.3% | +$3.6K | 0.08% | 87 |
|
|
2024
Q3 | $1.84M | Sell |
4,520
-161
| -3% | -$65.4K | 0.11% | 74 |
|
|
2024
Q2 | $1.5M | Buy |
4,681
+1,378
| +42% | +$443K | 0.1% | 78 |
|
|
2024
Q1 | $1.1M | Buy |
3,303
+262
| +9% | +$87.4K | 0.07% | 92 |
|
|
2023
Q4 | $823K | Buy |
3,041
+32
| +1% | +$8.66K | 0.06% | 105 |
|
|
2023
Q3 | $740K | Buy |
3,009
+266
| +10% | +$65.4K | 0.06% | 108 |
|
|
2023
Q2 | $832K | Buy |
2,743
+60
| +2% | +$18.2K | 0.07% | 103 |
|
|
2023
Q1 | $707K | Buy |
2,683
+349
| +15% | +$92K | 0.06% | 112 |
|
|
2022
Q4 | $560K | Sell |
2,334
-106
| -4% | -$25.4K | 0.05% | 116 |
|
|
2022
Q3 | $448K | Buy |
2,440
+180
| +8% | +$33K | 0.05% | 128 |
|
|
2022
Q2 | $380K | Buy |
2,260
+55
| +2% | +$9.25K | 0.04% | 145 |
|
|
2022
Q1 | $553K | Buy |
2,205
+658
| +43% | +$165K | 0.05% | 122 |
|
|
2021
Q4 | $397K | Buy |
+1,547
| New | +$397K | 0.04% | 142 |
|